ImmuPharma plc (LON:IMM – Get Free Report)’s stock price traded up 9.3% during mid-day trading on Saturday . The stock traded as high as GBX 4.50 ($0.06) and last traded at GBX 3.94 ($0.05). 31,560,066 shares were traded during trading, an increase of 60% from the average session volume of 19,683,289 shares. The stock had previously closed at GBX 3.60 ($0.04).
ImmuPharma Price Performance
The company has a fifty day simple moving average of GBX 1.75 and a two-hundred day simple moving average of GBX 1.73. The company has a market capitalization of £16.39 million, a P/E ratio of -393.60 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Further Reading
- Five stocks we like better than ImmuPharma
- What is the Shanghai Stock Exchange Composite Index?
- MarketBeat Week in Review – 01/20 – 01/24
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Netflix Stock Positioned for Explosive Growth in 2025
- 3 Dividend Kings To Consider
- Why Energy Transfer Stock Could Soar to New Highs in 2025
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
